What's in Jazz Pharmaceuticals's pipeline?

Jazz Pharmaceuticals has 10 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Jazz Pharmaceuticals's portfolio?

Top competitors by shared drug class: , Alkermes Inc, Hisamitsu, Baxter, Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jazz-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Jazz Pharmaceuticals — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jazz Pharmaceuticals pipeline: 7 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Zepzelca	LURBINECTEDIN	marketed	Alkylating Drug [EPC]		Oncology	2020-01-01
Clozaril	CLOZAPINE	marketed	Atypical Antipsychotic [EPC]	D2, 5-HT2A	Neuroscience	1989-01-01
Rapydan	Rapydan	marketed			Other
Sativex	Sativex	marketed			Neuroscience
Marinol	Marinol	marketed		N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1	Metabolic
Xyrem	Xyrem	marketed		Calcium/calmodulin-dependent protein kinase type II subunit alpha, GABA-B receptor, Gamma-hydroxybutyrate receptor	Other
Zepzelca	Zepzelca	marketed			Oncology

Therapeutic area mix

Other · 4
Neuroscience · 2
Oncology · 2
Immunology · 1
Metabolic · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2028-05-01 — Clozaril · 8057811 · Formulation · US

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
Alkermes Inc · 1 shared drug class
Hisamitsu · 1 shared drug class
Baxter · 1 shared drug class
Bayer · 1 shared drug class
Eli Lilly · 1 shared drug class
Azurity · 1 shared drug class
AbbVie · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jazz Pharmaceuticals:

Cite this brief

Drug Landscape (2026). Jazz Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jazz-pharmaceuticals. Accessed 2026-06-10.